Reply: Pleiotropic Effects of Ticagrelor Beyond Its Potent Antiplatelet Effects Contributing to Additional Clinical Benefits

JACC Cardiovasc Interv. 2018 Sep 10;11(17):1785-1786. doi: 10.1016/j.jcin.2018.06.041.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Clopidogrel*
  • Cross-Over Studies
  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride
  • Purinergic P2Y Receptor Antagonists
  • Ticagrelor*
  • Treatment Outcome

Substances

  • Biomarkers
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Clopidogrel
  • Prasugrel Hydrochloride
  • Ticagrelor